Mariner’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.9M Sell
332,710
-16,313
-5% -$1.26M 0.03% 421
2025
Q4
$27.7M Buy
349,023
+15,788
+5% +$1.24M 0.03% 363
2025
Q3
$25.1M Buy
333,235
+35,316
+12% +$2.42M 0.03% 372
2025
Q2
$20.5M Buy
297,919
+21,141
+8% +$1.39M 0.03% 404
2025
Q1
$18.8M Buy
276,778
+28,051
+11% +$1.68M 0.03% 394
2024
Q4
$11.2M Sell
248,727
-285,706
-53% -$16M 0.02% 509
2024
Q3
$33.6M Sell
534,433
-7,875
-1% -$459K 0.06% 267
2024
Q2
$32M Sell
542,308
-64,916
-11% -$4.06M 0.06% 253
2024
Q1
$48.4M Buy
607,224
+842
+0.1% +$64.3K 0.1% 196
2023
Q4
$47.9M Sell
606,382
-22,915
-4% -$1.63M 0.11% 177
2023
Q3
$43.9M Sell
629,297
-23,645
-4% -$1.68M 0.12% 170
2023
Q2
$45.1M Sell
652,942
-158,400
-20% -$11.3M 0.12% 170
2023
Q1
$60.3M Buy
811,342
+34,667
+4% +$2.91M 0.18% 120
2022
Q4
$72.4M Sell
776,675
-140
-0% -$13.5K 0.23% 99
2022
Q3
$74.1M Buy
776,815
+100,589
+15% +$9.96M 0.3% 83
2022
Q2
$62.7M Buy
676,226
+45,343
+7% +$4.43M 0.26% 96
2022
Q1
$63.9M Sell
630,883
-50,047
-7% -$5.26M 0.24% 101
2021
Q4
$70.2M Buy
680,930
+32,065
+5% +$2.96M 0.3% 86
2021
Q3
$55.1M Buy
648,865
+38,238
+6% +$3.2M 0.29% 91
2021
Q2
$51M Buy
610,627
+19,669
+3% +$1.61M 0.32% 91
2021
Q1
$44.5M Buy
590,958
+996
+0.2% +$72.5K 0.31% 95
2020
Q4
$40.3M Buy
589,962
+44,164
+8% +$2.87M 0.31% 95
2020
Q3
$31.9M Buy
545,798
+13,158
+2% +$819K 0.3% 97
2020
Q2
$34.6M Buy
532,640
+20,207
+4% +$1.27M 0.35% 86
2020
Q1
$30.4M Buy
512,433
+45,069
+10% +$3.01M 0.38% 74
2019
Q4
$34.7M Sell
467,364
-11,178
-2% -$785K 0.36% 82
2019
Q3
$30.2M Buy
478,542
+23,265
+5% +$1.38M 0.36% 81
2019
Q2
$24.8M Buy
455,277
+39,881
+10% +$2.15M 0.3% 93
2019
Q1
$22.4M Sell
415,396
-51,248
-11% -$3.16M 0.32% 90
2018
Q4
$30.5M Buy
466,644
+419,925
+899% +$31.3M 0.54% 47
2018
Q3
$3.68M Buy
46,719
+3,627
+8% +$259K 0.09% 203
2018
Q2
$2.77M Buy
43,092
+20,768
+93% +$1.37M 0.08% 225
2018
Q1
$1.39M Buy
22,324
+2,483
+13% +$178K 0.05% 268
2017
Q4
$1.44M Buy
19,841
+846
+4% +$61.5K 0.06% 244
2017
Q3
$1.54M Sell
18,995
-2,756
-13% -$218K 0.07% 208
2017
Q2
$1.75M Buy
21,751
+2,222
+11% +$175K 0.08% 184
2017
Q1
$1.53M Sell
19,529
-4,961
-20% -$396K 0.07% 223
2016
Q4
$1.93M Sell
24,490
-5,672
-19% -$459K 0.09% 188
2016
Q3
$2.69M Sell
30,162
-1,092
-3% -$103K 0.13% 148
2016
Q2
$2.99M Buy
31,254
+8,851
+40% +$882K 0.16% 131
2016
Q1
$2.32M Buy
22,403
+5,533
+33% +$538K 0.14% 143
2015
Q4
$1.65M Buy
16,870
+5,133
+44% +$503K 0.11% 162
2015
Q3
$1.13M Buy
11,737
+719
+7% +$75.6K 0.05% 232
2015
Q2
$1.16M Buy
11,018
+4,653
+73% +$475K 0.05% 225
2015
Q1
$657K Buy
6,365
+848
+15% +$85.8K 0.06% 220
2014
Q4
$531K Buy
5,517
+92
+2% +$8.11K 0.05% 236
2014
Q3
$432K Sell
5,425
-1,274
-19% -$100K 0.05% 231
2014
Q2
$505K Buy
6,699
+1,641
+32% +$124K 0.06% 225
2014
Q1
$379K Sell
5,058
-4,445
-47% -$314K 0.05% 230
2013
Q4
$680K Sell
9,503
-658
-6% -$42.3K 0.09% 191
2013
Q3
$577K Buy
10,161
+4,338
+74% +$258K 0.11% 177
2013
Q2
$333K Buy
+5,823
New +$337K 0.07% 199

Other funds holding CVS

Mariner's CVS Position: Q1 2026 in Review

Mariner reduced its CVS Health (CVS) stake by 4.7% in Q1 2026, selling an estimated $1.26M and leaving 332,710 shares worth $23.9M. The position accounts for 0.03% of the portfolio, ranked #421.

Mariner first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $74.1M in Q3 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Mariner held 332,710 shares of CVS Health worth $23.9M as of Q1 2026.
  • Mariner sold 16,313 CVS Health shares in Q1 2026, an estimated $1.26M.
  • CVS Health made up 0.03% of Mariner's portfolio in Q1 2026, its #421 holding.
  • Mariner first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Mariner's CVS Health position peaked at $74.1M in Q3 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.